|
1）糖尿病性腎症に関する合同委員会．改訂，糖尿病．2001; 44: 623
|
|
|
|
|
2）Araki S, Haneda M, Sugimoto T, et al. Factors associated with frequent remission of micro-albuminuria in patients with type 2 diabetes. Diabetes. 2005; 54: 2983-7
|
|
|
|
|
3）Makino H, Haneda M, Babazono T, et al. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study. Hypertens Res. 2008; 31: 657-64
|
|
|
|
|
4）Uzu T, Sawaguchi M, Maegawa H, et al. Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART). Diabetes Care. 2007; 30: 1581-3
|
|
|
|
|
|
5）Perkins BA, Nelson RG, Ostrander BE, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol. 2005; 16: 1404-12
|
|
|
|
|
|
6）Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003; 63: 225-32
|
|
|
|
|
|
7）Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348: 383-93
|
|
|
|
|
|
8）Gaede P, Lund-Andersen H, Parving HH, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358: 580-91
|
|
|
|
|
|
9）Shikata K, Haneda M, Koya D, et al. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design. Diabetes Res Clin Pract. 2010; 87: 228-32
|
|
|
|
|
|
10）Yamagata K, Makino H, Akizawa T, et al. Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan. Clin Exp Nephrol. 2010; 14: 144-151
|
|
|
|
|
|
11）Coca SG, Ismail-Beigi F, Haq N, et al. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med. 2012; 172: 761-9
|
|
|
|
|
|
12）日本腎臓学会，編．CKD診療ガイド2012．東京: 東京医学社; 2012
|
|
|
|
|
|
13）Slagman MC, Waanders F, Hemmelder MH, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ. 2011; 343: d4366
|
|
|
|
|
|
14）Vegter S, Perna A, Postma MJ, et al. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012; 23: 165-73
|
|
|
|
|
|
15）Houlihan CA, Allen TJ, Baxter AL, et al. A low-sodium diet potentiates the effects of losartan in type 2 diabetes. Diabetes Care. 2002; 25: 663-71
|
|
|
|
|
|
16）Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochloro-thiazide for hypertension in high-risk patients. N Engl J Med. 2008; 359: 2417-28
|
|
|
|
|
|
17）Ciavarella A, Di Mizio G, Stefoni S, et al. Reduced albuminuria after dietary protein restriction in insulin-dependent diabetic patients with clinical nephropathy. Diabetes Care. 1987; 10: 407-13
|
|
|
|
|
|
18）Zeller K, Whittaker E, Sullivan L, et al. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1991; 324: 78-84
|
|
|
|
|
|
19）Hansen HP, Tauber-Lassen E, Jensen BR, et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int. 2002; 62: 220-8
|
|
|
|
|
|
20）Pedrini MT, Levey AS, Lau J, et al. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med. 1996; 124: 627-32
|
|
|
|
|
|
21）Kasiske BL, Lakatua JD, Ma JZ, et al. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis. 1998; 31: 954-61
|
|
|
|
|
|
22）Pan Y, Guo LL, Jin HM. Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008; 88: 660-6
|
|
|
|
|
|
23）Koya D, Haneda M, Inomata S, et al. Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial. Diabetologia. 2009; 52: 2037-45
|
|
|
|
|
|
24）Walker JD, Bending JJ, Dodds RA, et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989; 2: 1411-5
|
|
|
|
|
|
25）島居美幸．糖尿病腎症の進行抑制．透析療法導入遅延に対して効果的な蛋白質制限量は? 糖尿病診療マスター．2008; 6: 408
|
|
|
|